Advertising disclosure — We may earn a commission if you start care through some of these links, at no extra cost to you. How we're funded. Order reflects our editorial rubric and our commercial relationships; scores are ours alone.
Head-to-head for women
Direct Meds vs Lttl
Direct Meds and Lttl both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.
Direct Meds
Ranked #26 for women · Grade B−
Luna Fit
Best for: Women who want an oral or sublingual alternative to weekly shots, on an all-inclusive program with no membership fee, and who are comfortable vetting a newer compounder themselves.
FDA warning letterSeptember 2025Read it ↗Visit Direct MedsLttl
Higher scoreRanked #21 for women · Grade B−
Luna Fit
Best for: Readers treating insulin resistance who want the month-to-month rate rather than a prepay rung, and who will open the plan selector: the real ladder is public, complete and honest, and it is one click from a headline figure that is not.
Visit LttlThe verdict for women
Lttl edges out Direct Meds on the Luna Fit Score, 81 to 80 (B− vs B−). Readers treating insulin resistance who want the month-to-month rate rather than a prepay rung, and who will open the plan selector: the real ladder is public, complete and honest, and it is one click from a headline figure that is not. The reasoning behind that number is in our Lttl write-up for women.
Direct Meds is still a genuine option — one of the few programs we track that offers an oral or sublingual route alongside injections — semaglutide drops from about $179 (or $297 injectable), tirzepatide from about $224 — all-inclusive with no separate membership. The trade-off is a newer, less-verified operator whose prices we couldn't confirm live. Weigh the six women's-health factors below against your own priorities; what we found reviewing Direct Meds goes through each of them, and if neither of these two is the one, the full field we rank against Direct Meds widens the field.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | Direct Meds | Lttl |
|---|---|---|
| Luna Fit Score | 80/100 · B− | 81/100 · B− |
| Overall rank | #26 | #21 |
| Semaglutide | $249/mo sublingual · $297/mo injectable | $199/mo month-to-month (from $129/mo on a 12-month plan billed $1,548 up front) — the product card advertises the $129 rung |
| Tirzepatide | $299/mo sublingual · $399/mo injectable | $279/mo month-to-month (from $199/mo on a 12-month plan billed $2,388 up front) — the product card advertises $129, which no tirzepatide tier costs |
| Coverage | Not publicly listed | All 50 states plus Washington D.C., with a stated caveat that some services may not be |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
Luna Fit
Direct Meds
Ranked #26 · Grade B−
What we like
- Rare oral and sublingual route in addition to injectable — a real option for the needle-averse
- Both molecules offered — semaglutide and tirzepatide for insulin-resistant PCOS
- All-inclusive pricing with no separate membership fee, and a promotional entry near $147
The caveats
- Compounded only — no FDA-approved brand semaglutide or tirzepatide
- Prices are company-stated, not ones we could verify live, and the brand runs multiple domains
- A newer operator with an ambiguous footprint, so the oversight signal is thinner
Luna Fit
Lttl
Ranked #21 · Grade B−
What we like
- Publishes its entire price ladder — every product, every term, every rung — in the public page source, each one labeled with what it bills (“$199/mo every month” beside “$1,548 annually”), with no intake quiz standing between you and the number
- A genuine month-to-month rung exists and is purchasable for every product, with no contracts and no minimum term, so the prepay ladder is an optional discount rather than the only way in
- Both molecules across three routes — injection, orally disintegrating tablet, and lower-dose microdose lines sold as their own products with their own published ladders rather than quoted at the full-dose price
The caveats
- All fourteen product cards hardcode “from $129/mo”. For semaglutide that is the twelve-month rung billed $1,548 up front; for tirzepatide, the semaglutide ODT and the microdose ODT it is a price purchasable at no tier at all
- The month-to-month rates are roughly 40% above the advertised figure — $199 for semaglutide and $279 for tirzepatide against the $129 on every card
- Names no medical director and no prescribing clinician, offers and requires no labs or bloodwork, and carries no third-party certification such as LegitScript
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Neither Direct Meds nor Lttl is only worth comparing with the other. Direct Meds is also written up against CoreAge Rx, 13 points apart on the Luna Fit Score — see Direct Meds vs CoreAge Rx for women. Lttl is also written up against CoreAge Rx, 12 points apart — see Lttl against CoreAge Rx, factor by factor.
- Direct Meds vs CoreAge Rx
- Direct Meds vs Enhance MD
- Direct Meds vs Eden
- Lttl vs yourEra
- Lttl vs Sesame Care
- Lttl vs HealthRX
Or browse the full comparison hub.